P.Glia

Neural cell culture technology/ unique cell isolation kits, reagents/ cell based platforms for biomarker & drug discovery/ neurodegeneration

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Bonn, NRW, Deutschland
  • Currency USD
  • Founded September 2010
  • Employees 3
  • Website pglia.com

Company Summary

P.Glia develops novel and efficient technologies for the isolation, culture and analysis of brain cells, neural/stem cell based models for biomarker & drug development related to neurodegeneration. Our mission: diagnostics, prevention and treatment of neurodegenerative diseases. Customers: research institutions (product line), neurologists/clinicians (in vitro diagnostics for personalized medicine), pharmaceutical companies (drug screening).

Team

  • Penka Pesheva
    Dr.

    Founder and president of P.Glia, PhD in neurobiology, until 2010 professor of neurobiology at University of Bonn, academic career at University of Heidelberg, Swiss Federal Institute of Technology Zurich and University of Bonn with research focus on matrix molecules in the regulation of axon growth and myelination, scientific advisor of Pharmacia Biotechnology (GE Healthcare), graduation in biochemistry & molecular biology at University of Sofia

  • Penka Pesheva, President of P.Glia

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free